VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness

Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.

NCT01638403 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of TS-091 in Patients with Narcolepsy

NCT03267303 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy

NCT01681121 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly Subjects

NCT05819710 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness

NCT01485770 ·Status: COMPLETED ·Phase: PHASE2

A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy

NCT01006122 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia

NCT05156047 ·Status: COMPLETED ·Phase: PHASE3

A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Solriamfetol in the Treatment of Excessive Daytime Sleepiness (EDS) in Patients with Obstructive Sleep Apnea (OSA)

NCT06103825 ·Status: COMPLETED ·Phase: PHASE3

This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation.

NCT05015673 ·Status: COMPLETED ·Phase: PHASE1

Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV)

NCT01789398 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP441 in Sleep-deprived Healthy Participants

NCT05651152 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period

NCT02611687 ·Status: COMPLETED ·Phase: PHASE3

Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia

NCT03772314 ·Status: COMPLETED ·Phase: PHASE2

Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder

NCT00758498 ·Status: COMPLETED ·Phase: PHASE3

VEC-162 Study in Adult Patients With Primary Insomnia

NCT00548340 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Tolerance of Solriamfetol in Patients Affected with Idiopathic Hypersomnia.

NCT06590662 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Phase III Study of TS-142 in Patients with Insomnia

NCT05453136 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model

NCT03284931 ·Status: COMPLETED ·Phase: PHASE1

Disturbed Sleep Model Study.

NCT00440323 ·Status: COMPLETED ·Phase: PHASE1

Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)

NCT01399606 ·Status: COMPLETED ·Phase: PHASE3

the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets

NCT04667429 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients

NCT02821715 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder

NCT01163032 ·Status: COMPLETED ·Phase: PHASE3

Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy Volunteers

NCT00368160 ·Status: COMPLETED ·Phase: PHASE1

Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)

NCT01800045 ·Status: COMPLETED ·Phase: PHASE3